McMaster University, 293 Wellington Street North, Suite 110, Hamilton, Ontario L8L 8E7, Canada.
BMC Musculoskelet Disord. 2010 May 6;11:85. doi: 10.1186/1471-2474-11-85.
Open fractures frequently result in serious complications for patients, including infections, wound healing problems, and failure of fracture healing, many of which necessitate subsequent operations. One of the most important steps in the initial management of open fractures is a thorough wound irrigation and debridement to remove any contaminants. There is, however, currently no consensus regarding the optimal approach to irrigating open fracture wounds during the initial operative procedure. The selection of both the type of irrigating fluid and the pressure of fluid delivery remain controversial. The primary objective of this study is to investigate the effects of irrigation solutions (soap vs. normal saline) and pressure (low vs. high; gravity flow vs. high; low vs. gravity flow) on re-operation within one year among patients with open fractures.
METHODS/DESIGN: The FLOW study is a multi-center, randomized controlled trial using a 2 x 3 factorial design. Surgeons at clinical sites in North America, Europe, Australia, and Asia will recruit 2 280 patients who will be centrally randomized into one of the 6 treatment arms (soap + low pressure; soap + gravity flow pressure; soap + high pressure; saline + low pressure; saline + gravity flow pressure; saline + high pressure). The primary outcome of the study is re-operation to promote wound or bone healing, or to treat an infection. This composite endpoint of re-operation includes a narrow spectrum of patient-important procedures: irrigation and debridement for infected wound, revision and closure for wound dehiscence, wound coverage procedures for infected or necrotic wound, bone grafts or implant exchange procedures for established nonunion in patients with postoperative fracture gaps less than 1 cm, intramedullary nail dynamizations in the operating room, and fasciotomies for compartment syndrome. Patients, outcome adjudicators, and data analysts will be blinded. We will compare rates of re-operation at 12 months across soap vs. saline, low pressure vs. high pressure, gravity flow pressure vs. high pressure, and low pressure vs. gravity flow pressure. We will measure function and quality of life with the Short Form-12 (SF-12) and the EuroQol-5 Dimensions (EQ-5D) at baseline, 2 weeks, 6 weeks, 3 months, 6 months, 9 months, and 12 months after initial surgical management, and measure patients' illness beliefs with the Somatic Pre-Occupation and Coping (SPOC) questionnaire at 1 and 6 weeks. We will also compare non-operatively managed infections, wound healing, and fracture healing problems at 12 months after initial surgery.
This study represents a major international effort to identify a simple and easily applicable strategy for emergency wound management. The importance of the question and the potential to identify a low cost treatment strategy argues strongly for global participation, especially in low and middle income countries such as India and China where disability from traumatic injuries is substantial.
This trial is registered at ClinicalTrials.gov (NCT00788398).
开放性骨折常导致患者出现严重并发症,包括感染、伤口愈合问题和骨折愈合失败等,其中许多需要后续手术治疗。开放性骨折初始处理中最重要的步骤之一是彻底冲洗和清创,以清除任何污染物。然而,目前对于在初始手术过程中冲洗开放性骨折伤口的最佳方法尚无共识。冲洗液的选择(肥皂液与生理盐水)和冲洗压力(低与高;重力流与高压;低与重力流)仍存在争议。本研究的主要目的是调查冲洗液(肥皂液与生理盐水)和冲洗压力(低与高;重力流与高压;低与重力流)对开放性骨折患者一年内再次手术的影响。
方法/设计:FLOW 研究是一项多中心、随机对照试验,采用 2 x 3 析因设计。北美、欧洲、澳大利亚和亚洲的临床站点的外科医生将招募 2280 名患者,他们将被中央随机分为 6 个治疗组之一(肥皂液+低压力;肥皂液+重力流压力;肥皂液+高压力;生理盐水+低压力;生理盐水+重力流压力;生理盐水+高压力)。该研究的主要结局是再次手术以促进伤口或骨骼愈合,或治疗感染。这种再手术的复合终点包括一系列对患者重要的手术:感染性伤口的冲洗和清创、伤口裂开的修复和闭合、感染或坏死性伤口的伤口覆盖程序、术后骨折间隙小于 1cm 时用于非愈合的骨移植或植入物更换程序、手术室髓内钉动力化以及用于筋膜间室综合征的筋膜切开术。患者、结局评估者和数据分析者将被设盲。我们将比较肥皂液与生理盐水、低压力与高压力、重力流压力与高压和低压力与重力流压力在 12 个月时的再手术率。我们将使用 SF-12 和 EQ-5D 在基线、2 周、6 周、3 个月、6 个月、9 个月和 12 个月时测量功能和生活质量,并在 1 周和 6 周时使用躯体前occupation 和应对(SPOC)问卷测量患者的疾病信念。我们还将比较初次手术后 12 个月时非手术治疗的感染、伤口愈合和骨折愈合问题。
这项研究代表了一项重要的国际努力,旨在确定一种简单且易于应用的紧急伤口管理策略。该问题的重要性以及确定低成本治疗策略的潜力强烈呼吁全球参与,特别是在印度和中国等中低收入国家,创伤性损伤导致的残疾情况较为严重。
该试验在 ClinicalTrials.gov 注册(NCT00788398)。